SILVERARC CAPITAL MANAGEMENT, LLC URGN Holdings History
SILVERARC CAPITAL MANAGEMENT, LLC's UroGen Pharma Ltd Holding Summary
As of 2025-03-31, SILVERARC CAPITAL MANAGEMENT, LLC held 1.38 Mil shares of UroGen Pharma Ltd(URGN), totaling $15.28 Mil. This investment constitutes 3.12% of their stock portfolio, and SILVERARC CAPITAL MANAGEMENT, LLC now holds 3% of the outstanding UroGen Pharma Ltd(URGN) stock.
The initial trade took place in 2023Q3. And since then SILVERARC CAPITAL MANAGEMENT, LLC has made 5 purchases of URGN, at an average price of $13.90, for a total of 1.60 Mil shares. In addition, there have been 2 sales at an average price of $14.96 for 217,688.00 shares. Based on historical transaction data and URGN's current price of $15.27, SILVERARC CAPITAL MANAGEMENT, LLC's estimated gain on his URGN holdings is $2.12 Mil, reflecting a 9.56% gain to date.
SILVERARC CAPITAL MANAGEMENT, LLC URGN ($15.27) Holding Chart
SILVERARC CAPITAL MANAGEMENT, LLC URGN ($15.27) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1